Last edition
News about "dry eye disease"
China Approves Hengrui Pharma's Water-Free Cyclosporine Eye Drop for Dry Eye Disease
China's drug regulator has approved Hengrui Pharma's Heng Yi, the country's first water-free 0.1 percent cyclosporine ophthalmic solution, expanding treatment options for patients with dry eye disease through Novaliq's EyeSol technology.
Dry Eye Disease | 03/07/2026 | By News Bureau | 102
China Approves Hengrui Pharma's Water-Free Cyclosporine Eye Drop for Dry Eye Disease
China's drug regulator has approved Hengrui Pharma's Heng Yi, the country's first water-free 0.1 percent cyclosporine ophthalmic solution, expanding treatment options for patients with dry eye disease through Novaliq's EyeSol technology.
Dry Eye Disease | 03/07/2026 | By News Bureau | 102
Saptalis Launches Cyclosporine Ophthalmic Emulsion
Saptalis Pharmaceuticals has launched Cyclosporine Ophthalmic Emulsion 0.05 percent in 30- and 60-count single-use vials, expanding its ophthalmology portfolio and improving access to high-quality treatment options for patients.
Dry Eye Disease | 16/06/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy